Shanghai Pharmaceuticals Holding Co., Ltd (S1R.F)

1,3000 +0,0200 (+1,56%) Ab 10:30AM CEST. Markt geöffnet.

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

Sektor(en): Healthcare
Branche: Medical Distribution
Vollzeitmitarbeiter: 48.164

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Qiuhua Yang	Executive Chairman	N/A	N/A	1972
Mr. Bo Shen	President, CFO, Head of the Accounting Department & Executive Director	730,1k	N/A	1973
Mr. Yongzhong Li	VP & Executive Director	780,47k	N/A	1970
Mr. Ming Dong	Executive Director	N/A	N/A	1976
Mr. Tao Zhong	VP, Board Secretary & Joint Company Secretary	N/A	N/A	1972
Mr. Dongming Li	Vice President	N/A	N/A	1969
Ms. Shuai Shao	Vice President	N/A	N/A	1988
Dr. Shunjiang Yu	Chief Medical Officer	N/A	N/A	N/A
Ms. Pui Kiu Wong	Joint Company Secretary	N/A	N/A	N/A
Ying Ke	Director & General Manager of R&D Management Center	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Corporate Governance

Shanghai Pharmaceuticals Holding Co., Ltds ISS Governance QualityScore, Stand 1. April 2024, lautet 8. Die grundlegenden Scores sind Audit: 7, Vorstand: 10, Shareholderrechte: 9, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.